SCHEMBL14192097

SCHEMBL14192097

CC(=O)NCC1OCCCO1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.38
FUCA1 P04066 1/20 0.38
USP2 O75604 1/20 0.38
HPGD P15428 3/20 0.37
TP53 P04637 1/20 0.37
ALOX12 P18054 1/20 0.37
MTNR1A P48039 1/20 0.37
GLA P06280 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
NPSR1 Q6W5P4 2/20 0.35
ACACB O00763 1/20 0.35
ACACA Q13085 1/20 0.35
HTT P42858 1/20 0.35
ALDH1A1 P00352 1/20 0.35
APOBEC3A P31941 1/20 0.35
APOBEC3G Q9HC16 1/20 0.35
KDM4E B2RXH2 1/20 0.34
MAPK1 P28482 1/20 0.34
HIF1A Q16665 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12019192 0.91 FUCA1 (0.40) FUCA1MTNR1AGLANPSR1ACACB
SCHEMBL11440524 0.83 SMN1; SMN2 (0.38) SMN1; SMN2USP2HPGDTP53ALOX12
SCHEMBL14169154 0.78 KMT2A (0.36) SMN1; SMN2USP2HPGDTP53ALOX12
SCHEMBL1101625 0.78 SMN1; SMN2 (0.64) SMN1; SMN2USP2HPGDTP53ALOX12
SCHEMBL12409226 0.78 SMN1; SMN2 (0.64) SMN1; SMN2USP2HPGDTP53ALOX12
SCHEMBL12409354 0.78 SMN1; SMN2 (0.64) SMN1; SMN2USP2HPGDTP53ALOX12
SCHEMBL15492723 0.76 SMN1; SMN2 (0.57) SMN1; SMN2USP2HPGDTP53ALOX12
SCHEMBL11263303 0.75 SMN1; SMN2 (0.43) SMN1; SMN2USP2HPGDTP53ALOX12
SCHEMBL31677770 0.74
SCHEMBL4663635 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7375108-B2 2-substituted pyrimidines BASF AKTIENGESELLSCHAFT (DE) 2008-05-20 US disclosed
US-20070105873-A1 2-Substituted pyrimidines BASF AKTIENGESELLSCHAFT (DE) 2007-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070105873-A1 2-Substituted pyrimidines TYMP, RRM2, TYMS SMN1; SMN2 1782/4885FUCA1 3920/4885USP2 3363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.